Alain Bols

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

<i>TP53</i> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

Bram De Laere, Steffi Oeyen, Markus Mayrhofer et al. · Clinical Cancer Research · 2018 · 161 citations · Full text

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Markus Mayrhofer, Bram De Laere, Tom Whitington et al. · Genome Medicine · 2018 · 128 citations · Full text

Model-based Iterative Reconstruction and Adaptive Statistical Iterative Reconstruction Techniques in Abdominal CT: Comparison of Image Quality in the Detection of Colorectal Liver Metastases

David Volders, Alain Bols, Marc Haspeslagh et al. · Radiology · 2013 · 102 citations

Epidermal Growth Factor Receptor and K-RAS status in two cohorts of squamous cell carcinomas

Nancy Van Damme, Philippe Deron, Nadine Van Roy et al. · BMC Cancer · 2010 · 79 citations · Full text